Current Headlines

  1. American Airlines Cargo Begins Work On State-Of-The-Art Pharmaceutical Facility In Philadelphia
    8/26/2014

    American Airlines Cargo has started construction of a dedicated pharmaceutical handling facility in Philadelphia, PA.

  2. Scientists Turn To Pomegranate To Develop Dementia Drugs
    8/26/2014

    Scientists from the University of Huddersfield reported that dementia and neuro-inflammation may be curbed by a natural compound found in pomegranate.

  3. Emergent And MorphoSys To Co-Develop Prostate Cancer Drug
    8/26/2014

    Emergent BioSolutions announced that it has signed an agreement with therapeutic antibody specialist firm MorphoSys to co-develop and commercialize its preclinical bi-specific antibody ES414 as treatment for prostate cancer.

  4. Insys Therapeutics’ Cannabidiol Granted Another Orphan Drug Designation
    8/26/2014

    Insys Therapeutics announced that the FDA has granted another orphan drug designation (ODD) for its pharmaceutical cannabidiol (CBD) for the treatment of glioblastoma multiforme (GBM), a common and aggressive form of malignant brain tumor. This is the second such designation for Insys’ CBD and the third for cannabis-based pharmaceuticals.

  5. Miriam Monge To Join Sartorius Stedim Biotech As Director Of Marketing For Integrated Solutions
    8/26/2014

    Sartorius Stedim Biotech (SSB), a leading international pharma and biotech supplier, today announced the appointment of Miriam Monge as Director of Marketing for SSB’s Integrated Solutions unit.

  6. AstraZeneca Partners With Illumina For Gene Sequencing
    8/25/2014

    U.K. pharma giant AstraZeneca announced that it has partnered with Illumina, a gene sequencing firm, for the development of its next generation sequencing (NGS) platform and produce companion diagnostic tests applicable to AstraZeneca’s oncology portfolio.

  7. Pfizer And CCFA Collaborate For IBD Research
    8/25/2014

    Pfizer announced that it has linked with the Crohn’s & Colitis Foundation of America (CCFA) through its Centers for Therapeutic Innovation (CTI) to advance research in inflammatory bowel disease (IBD).

  8. Regeneus Enters Partnership With Cryosite For New Stem Cell Products
    8/25/2014

    Australian regenerative medicine company, Regeneus, has just entered a new collaboration with Cryosite, an Australian biotech company, for the development and manufacture of new stem cell products for human applications. This agreement will help to fast-track the production of Regeneus' novel stem cell therapy for osteoarthritis, Progenza, to make it available for preclinical and clinical trials for market entry into Japan.

  9. HUYA And Changzhou Center Link Arms In Drug Development
    8/22/2014

    HUYA Bioscience International, a China-based international drug development firm, and Changzhou Center for Biotech Development (CZCBD) announced a strategic collaboration to advance innovations from bio-pharmaceutical companies located in Changzhou that have the potential to meet pharmaceutical needs in the global arena.

  10. New Vaccine Puts Up Stronger Fight Against Both Tuberculosis And Leprosy
    8/22/2014

    Researchers at the University of California Los Angeles have prepared a new and improved variant of an existing vaccine, which is found to offer stronger protection against the two major infectious diseases, tuberculosis (TB) and leprosy. The study has been published in the journal Infection and Immunity.